MACROGENICS INC·4

May 20, 4:13 PM ET

Chhabra Meenu 4

4 · MACROGENICS INC · Filed May 20, 2026

Research Summary

AI-generated summary of this filing

Updated

MacroGenics (MGNX) Director Meenu Chhabra Receives RSU Award

What Happened Meenu Chhabra, a director of MacroGenics, had restricted stock units (RSUs) vest and reported conversions/exercises of derivative holdings in a Form 4 covering May 18–19, 2026. The filing shows acquisitions of 22,000 RSUs and 3,750 RSUs (total 25,750 shares) reported on 2026-05-19 (listed at $0.00 per share as derivative awards). The report also shows a 3,750-share exercise/conversion on 2026-05-18 with a matching 3,750-share disposition at $0.00 (derivative). These entries reflect compensation-related vesting/conversion activity rather than open-market purchases or sales.

Key Details

  • Transaction dates and amounts:
    • 2026-05-18: exercise/conversion (code M) — 3,750 shares acquired (price N/A) and a 3,750-share disposition at $0.00 (derivative).
    • 2026-05-19: grant/award (code A) — 22,000 shares @ $0.00 (derivative).
    • 2026-05-19: grant/award (code A) — 3,750 shares @ $0.00 (derivative).
  • Total reported newly acquired derivative shares: 25,750 (22,000 + 3,750); the 3,750 exercise on 5/18 is shown alongside a 3,750-share $0 disposition.
  • Shares owned after the transactions: not specified in the provided filing excerpt.
  • Footnotes of note:
    • F1: Each RSU converts to one share of common stock when settled.
    • F3/F4: The RSUs vested on May 18, 2026 (one day before the 2026 annual meeting); the filings list related awards on May 19.
    • F2 (option vesting schedule) applies to prior option grants; not directly priced here.
  • Timeliness: no late filing indicator was provided in the supplied data.

Context

  • These entries are derivative/award-related (RSU vesting and a conversion/exercise) and are typically compensation-driven rather than discretionary market buys or sales. The $0.00 amounts reflect that the shares resulted from vesting/settlement of equity awards, not cash purchases. The 3,750-share $0 disposition reported the same day as a conversion commonly indicates net settlement or tax-related surrender of shares, though the filing here does not explicitly state the reason.

Insider Transaction Report

Form 4
Period: 2026-05-18
Transactions
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-05-18+3,75014,750 total
  • Award

    Stock Option (right to buy)

    [F2]
    2026-05-19+22,00022,000 total
    Exercise: $4.52Exp: 2036-05-19Common Stock (22,000 underlying)
  • Award

    Restricted Stock Unit

    [F1][F3]
    2026-05-19+3,7503,750 total
    Exercise: $0.00Common Stock (3,750 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    [F1][F4]
    2026-05-183,7500 total
    Exercise: $0.00Common Stock (3,750 underlying)
Footnotes (4)
  • [F1]Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock.
  • [F2]The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant.
  • [F3]The RSUs will vest one year after the date of grant, or the day prior to the next annual meeting, if earlier
  • [F4]The RSUs vested on May 18, 2026, which was one day prior to the Issuer's 2026 Annual Meeting of Stockholders held on May 19, 2026.
Signature
Beth A. Smith, Attorney-in-fact|2026-05-20

Documents

1 file
  • 4
    wk-form4_1779308021.xmlPrimary

    FORM 4